Annual FCF
-$11.13 M
+$2.14 M+16.12%
September 30, 2024
Summary
- As of February 8, 2025, NMTC annual free cash flow is -$11.13 million, with the most recent change of +$2.14 million (+16.12%) on September 30, 2024.
- During the last 3 years, NMTC annual FCF has fallen by -$2.46 million (-28.40%).
- NMTC annual FCF is now -218174.51% below its all-time high of -$5100.00, reached on December 31, 2010.
Performance
NMTC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.70 M
-$328.60 K-13.83%
September 30, 2024
Summary
- As of February 8, 2025, NMTC quarterly free cash flow is -$2.70 million, with the most recent change of -$328.60 thousand (-13.83%) on September 30, 2024.
- Over the past year, NMTC quarterly FCF has increased by +$256.60 thousand (+8.67%).
- NMTC quarterly FCF is now -384.13% below its all-time high of $951.60 thousand, reached on September 30, 2022.
Performance
NMTC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$11.13 M
+$256.60 K+2.25%
September 30, 2024
Summary
- As of February 8, 2025, NMTC TTM free cash flow is -$11.13 million, with the most recent change of +$256.60 thousand (+2.25%) on September 30, 2024.
- Over the past year, NMTC TTM FCF has increased by +$2.14 million (+16.12%).
- NMTC TTM FCF is now -173837.50% below its all-time high of -$6400.00, reached on September 30, 2016.
Performance
NMTC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NMTC Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +16.1% | +8.7% | +16.1% |
3 y3 years | -28.4% | +1.3% | -17.1% |
5 y5 years | -101.7% | -118.9% | -83.9% |
NMTC Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -42.8% | +16.1% | -384.1% | +29.7% | -42.8% | +18.2% |
5 y | 5-year | -213.8% | +16.1% | -384.1% | +29.7% | -213.8% | +18.2% |
alltime | all time | <-9999.0% | +16.1% | -384.1% | +29.7% | <-9999.0% | +18.2% |
NeuroOne Medical Technologies Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | -$11.13 M(-16.1%) | -$2.70 M(+13.8%) | -$11.13 M(-2.3%) |
Jun 2024 | - | -$2.38 M(+7.6%) | -$11.39 M(-5.8%) |
Mar 2024 | - | -$2.21 M(-42.6%) | -$12.09 M(-11.2%) |
Dec 2023 | - | -$3.85 M(+29.9%) | -$13.61 M(+2.6%) |
Sep 2023 | -$13.27 M(+70.3%) | -$2.96 M(-3.9%) | -$13.27 M(+41.8%) |
Jun 2023 | - | -$3.08 M(-17.4%) | -$9.36 M(+4.3%) |
Mar 2023 | - | -$3.73 M(+6.4%) | -$8.97 M(+4.8%) |
Dec 2022 | - | -$3.50 M(-468.2%) | -$8.56 M(+9.8%) |
Sep 2022 | -$7.79 M(-10.1%) | $951.60 K(-135.4%) | -$7.79 M(-27.9%) |
Jun 2022 | - | -$2.69 M(-18.8%) | -$10.81 M(+3.6%) |
Mar 2022 | - | -$3.31 M(+21.0%) | -$10.44 M(+9.8%) |
Dec 2021 | - | -$2.74 M(+32.8%) | -$9.51 M(+9.6%) |
Sep 2021 | -$8.67 M(+144.4%) | -$2.06 M(-11.0%) | -$8.67 M(+35.7%) |
Jun 2021 | - | -$2.32 M(-2.6%) | -$6.39 M(+20.1%) |
Mar 2021 | - | -$2.38 M(+25.1%) | -$5.32 M(+26.1%) |
Dec 2020 | - | -$1.90 M(-980.4%) | -$4.22 M(+18.9%) |
Sep 2020 | -$3.55 M(-35.7%) | $216.30 K(-117.3%) | -$3.55 M(-27.8%) |
Jun 2020 | - | -$1.25 M(-2.5%) | -$4.91 M(-8.9%) |
Mar 2020 | - | -$1.28 M(+3.7%) | -$5.39 M(-10.9%) |
Dec 2019 | - | -$1.24 M(+7.7%) | -$6.05 M(+9.7%) |
Sep 2019 | -$5.52 M(+141.6%) | -$1.15 M(-33.7%) | -$5.52 M(+26.2%) |
Jun 2019 | - | -$1.73 M(-10.9%) | -$4.37 M(+28.6%) |
Mar 2019 | - | -$1.94 M(+177.5%) | -$3.40 M(+65.9%) |
Dec 2018 | - | -$699.70 K(-7.8%) | -$2.05 M(-19.5%) |
Sep 2018 | -$2.28 M(+3.8%) | - | - |
Jun 2018 | - | -$758.60 K(+28.3%) | -$2.54 M(+8.4%) |
Mar 2018 | - | -$591.30 K(-1.2%) | -$2.35 M(+11.4%) |
Dec 2017 | -$2.20 M | -$598.40 K(+0.3%) | -$2.11 M(+37.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | -$596.50 K(+6.1%) | -$1.53 M(+65.3%) |
Jun 2017 | - | -$562.20 K(+60.2%) | -$926.00 K(+148.9%) |
Mar 2017 | - | -$350.90 K(+1563.0%) | -$372.00 K(+1663.0%) |
Dec 2016 | -$21.10 K(-30.1%) | -$21.10 K(-357.3%) | -$21.10 K(+229.7%) |
Sep 2016 | - | $8200.00(-200.0%) | -$6400.00(-64.2%) |
Jun 2016 | - | -$8200.00(<-9900.0%) | -$17.90 K(+67.3%) |
Mar 2016 | - | $0.00(-100.0%) | -$10.70 K(-64.7%) |
Dec 2015 | -$30.20 K(+15.3%) | -$6400.00(+93.9%) | -$30.30 K(-7.9%) |
Sep 2015 | - | -$3300.00(+230.0%) | -$32.90 K(-29.9%) |
Jun 2015 | - | -$1000.00(-94.9%) | -$46.90 K(+2.6%) |
Mar 2015 | - | -$19.60 K(+117.8%) | -$45.70 K(+75.1%) |
Dec 2014 | -$26.20 K(+4.4%) | -$9000.00(-48.0%) | -$26.10 K(+32.5%) |
Sep 2014 | - | -$17.30 K(-8750.0%) | -$19.70 K(+177.5%) |
Jun 2014 | - | $200.00(>+9900.0%) | -$7100.00(-67.9%) |
Mar 2014 | - | $0.00(-100.0%) | -$22.10 K(-12.0%) |
Dec 2013 | -$25.10 K(+83.2%) | -$2600.00(-44.7%) | -$25.10 K(+5.0%) |
Sep 2013 | - | -$4700.00(-68.2%) | -$23.90 K(+0.4%) |
Jun 2013 | - | -$14.80 K(+393.3%) | -$23.80 K(+110.6%) |
Mar 2013 | - | -$3000.00(+114.3%) | -$11.30 K(-18.1%) |
Dec 2012 | -$13.70 K(-50.0%) | -$1400.00(-69.6%) | -$13.80 K(-50.5%) |
Sep 2012 | - | -$4600.00(+100.0%) | -$27.90 K(+1.8%) |
Jun 2012 | - | -$2300.00(-58.2%) | -$27.40 K(+4.2%) |
Mar 2012 | - | -$5500.00(-64.5%) | -$26.30 K(-4.4%) |
Dec 2011 | -$27.40 K(+437.3%) | -$15.50 K(+278.0%) | -$27.50 K(+129.2%) |
Sep 2011 | - | -$4100.00(+241.7%) | -$12.00 K(+51.9%) |
Jun 2011 | - | -$1200.00(-82.1%) | -$7900.00(+17.9%) |
Mar 2011 | - | -$6700.00 | -$6700.00 |
Dec 2010 | -$5100.00 | - | - |
FAQ
- What is NeuroOne Medical Technologies annual free cash flow?
- What is the all time high annual FCF for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies annual FCF year-on-year change?
- What is NeuroOne Medical Technologies quarterly free cash flow?
- What is the all time high quarterly FCF for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies quarterly FCF year-on-year change?
- What is NeuroOne Medical Technologies TTM free cash flow?
- What is the all time high TTM FCF for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies TTM FCF year-on-year change?
What is NeuroOne Medical Technologies annual free cash flow?
The current annual FCF of NMTC is -$11.13 M
What is the all time high annual FCF for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high annual free cash flow is -$5100.00
What is NeuroOne Medical Technologies annual FCF year-on-year change?
Over the past year, NMTC annual free cash flow has changed by +$2.14 M (+16.12%)
What is NeuroOne Medical Technologies quarterly free cash flow?
The current quarterly FCF of NMTC is -$2.70 M
What is the all time high quarterly FCF for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high quarterly free cash flow is $951.60 K
What is NeuroOne Medical Technologies quarterly FCF year-on-year change?
Over the past year, NMTC quarterly free cash flow has changed by +$256.60 K (+8.67%)
What is NeuroOne Medical Technologies TTM free cash flow?
The current TTM FCF of NMTC is -$11.13 M
What is the all time high TTM FCF for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high TTM free cash flow is -$6400.00
What is NeuroOne Medical Technologies TTM FCF year-on-year change?
Over the past year, NMTC TTM free cash flow has changed by +$2.14 M (+16.12%)